Matthew Gourmand - Omega Healthcare IR Contact Officer

OHI Stock  USD 40.11  0.03  0.07%   

Executive

Matthew Gourmand is IR Contact Officer of Omega Healthcare Investors since 2018.
Age 48
Tenure 6 years
Address 303 International Circle, Hunt Valley, MD, United States, 21030-1394
Phone410 427 1700
Webhttps://www.omegahealthcare.com

Omega Healthcare Management Efficiency

The company has Return on Asset of 0.039 % which means that on every $100 spent on assets, it made $0.039 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0867 %, implying that it generated $0.0867 on every 100 dollars invested. Omega Healthcare's management efficiency ratios could be used to measure how well Omega Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.03. The current Return On Capital Employed is estimated to decrease to 0.08. As of now, Omega Healthcare's Other Assets are increasing as compared to previous years. The Omega Healthcare's current Other Current Assets is estimated to increase to about 113 M, while Total Current Assets are projected to decrease to under 664.3 M.
Omega Healthcare Investors has 5.07 B in debt with debt to equity (D/E) ratio of 1.35, which is OK given its current industry classification. Omega Healthcare Inv has a current ratio of 2.52, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Omega to invest in growth at high rates of return.

Similar Executives

Showing other executives

EXECUTIVE Age

Andrew CFAHealthpeak Properties
N/A
Stephen SwettGlobal Medical REIT
N/A
Ronald HubbardHealthcare Realty Trust
N/A
Timothy SandersVentas Inc
N/A
Becca OberlanderHealthcare Realty Trust
N/A
Thomas KlaritchHealthpeak Properties
66
James CroyHealthpeak Properties
N/A
Gayle CapozzaloUniversal Health Realty
70
Robert McCaddenUniversal Health Realty
62
Mark LambCareTrust REIT
46
Ankit PatadiaHealthpeak Properties
46
Austen HelfrichHealthcare Realty Trust
N/A
Lauren BealeCareTrust REIT
N/A
Justin HutchensVentas Inc
49
Judith RomeroUniversal Health Realty
N/A
Leanne DavisLTC Properties
N/A
Lukas CFASabra Healthcare REIT
N/A
Karla PetersonUniversal Health Realty
64
Albert BlackHealthpeak Properties
61
Julie RobinsonVentas Inc
N/A
James CallisterCareTrust REIT
48
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. The assets span all regions within the US, as well as in the UK. Omega Healthcare operates under REITHealthcare Facilities classification in the United States and is traded on New York Stock Exchange. It employs 70 people. Omega Healthcare Investors (OHI) is traded on New York Stock Exchange in USA. It is located in 303 International Circle, Hunt Valley, MD, United States, 21030-1394 and employs 57 people. Omega Healthcare is listed under Diversified REITs category by Fama And French industry classification.

Management Performance

Omega Healthcare Inv Leadership Team

Elected by the shareholders, the Omega Healthcare's board of directors comprises two types of representatives: Omega Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Omega. The board's role is to monitor Omega Healthcare's management team and ensure that shareholders' interests are well served. Omega Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Omega Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Taylor CPA, CEO Director
Gail JD, Chief Counsel
Matthew Gourmand, IR Contact Officer
Kapila Anand, Independent Director
Neal Ballew, Senior Vice President Chief Accounting Officer
Burke Whitman, Independent Director
Edward Lowenthal, Independent Director
Craig Callen, Independent Chairman of the Board
Samuel Kovitz, Senior VP
C Pickett, Chief Executive Officer, Director
Daniel Booth, Chief Operating Officer
Kevin Jacobs, Independent Director
Megan Krull, Senior Operations
Michele Reber, Director Management
Robert Stephenson, Chief Financial Officer
Steven Insoft, Chief Corporate Development Officer
Michael Ritz, Chief Accounting Officer
Gail Makode, Chief Legal Officer, General Counsel
Stephen Plavin, Independent Director
Matthew CPA, Senior Relations
Barbara Hill, Independent Director
Lisa EgbuonuDavis, Director
Vikas Gupta, Senior Development

Omega Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Omega Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.137
Dividend Share
2.68
Earnings Share
1.36
Revenue Per Share
4.03
Quarterly Revenue Growth
0.14
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.